Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Histopathology and Classification of Renal Cell Tumors (Adenomas, Oncocytomas and Carcinomas)
1986536 citationsW. Thoenes, S Störkel et al.profile →
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
This map shows the geographic impact of S Störkel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S Störkel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S Störkel more than expected).
This network shows the impact of papers produced by S Störkel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S Störkel. The network helps show where S Störkel may publish in the future.
Co-authorship network of co-authors of S Störkel
This figure shows the co-authorship network connecting the top 25 collaborators of S Störkel.
A scholar is included among the top collaborators of S Störkel based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with S Störkel. S Störkel is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
All Works
20 of 20 papers shown
1.
Velickovic, Marija, et al.. (2001). VHL and FHIT locus loss of heterozygosity is common in all renal cancer morphotypes but differs in pattern and prognostic significance.. PubMed. 61(12). 4815–9.47 indexed citations
2.
Brauch, Hiltrud, Gregor Weirich, Juergen Brieger, et al.. (2000). VHL alterations in human clear cell renal cell carcinoma: association with advanced tumor stage and a novel hot spot mutation.. PubMed. 60(7). 1942–8.181 indexed citations
3.
Gerharz, Claus‐Dieter, R. Moll, S Störkel, et al.. (1995). Establishment and characterization of two divergent cell lines derived from a human chromophobe renal cell carcinoma.. PubMed. 146(4). 953–62.23 indexed citations
4.
Runkel, M., et al.. (1994). [Bone remodeling after reamed and unreamed intramedullary nailing. A histomorphometric study].. PubMed. 97(8). 385–90.21 indexed citations
5.
Wenda, K., et al.. (1991). [Interpretation of MR tomography findings in trauma surgery].. PubMed. 94(6). 302–7.3 indexed citations
Schweden, F, C Düber, Hans H. Schild, et al.. (1988). Das Onkozytom der Niere. RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren. 148(2). 137–142.1 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.